Zacks Investment Research on MSN4h
JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's Disease
Johnson & Johnson JNJ announced that the FDA has granted a Fast Track designation (“FTD’) to its investigational drug, ...
FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
Johnson & Johnson's nipocalimab receives FDA Fast Track status for Sjögren's disease, following strong Phase 2 trial results ...
Johnson & Johnson says FDA grants Fast Track designation to nipocalimab
Johnson & Johnson announced that the U.S. FDA has granted investigational nipocalimab Fast Track designation for the treatment of adult ...
J&J gets FDA Fast Track status for nipocalimab in Sjogren's
Johnson & Johnson's nipocalimab earns FDA Fast Track status for Sjögren's disease, speeding development and review for unmet medical needs.
Healio1d
Nipocalimab nets FDA fast-track designation for Sjögren’s disease
The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...
MassDevice7d
Johnson & Johnson MedTech wins FDA nod for enhanced robotic-assisted bronchoscopy
Johnson & Johnson MedTech announced today that the FDA cleared its Monarch Quest technology for robotic-assisted bronchoscopy ...
Modern Healthcare7d
J&J MedTech gets FDA clearance for robotic bronchoscopy platform
Johnson & Johnson MedTech said Wednesday its Monarch Quest robotic platform received clearance from the Food and Drug ...
Managed Healthcare Executive7d
FDA Approves First Generics of Xarelto
Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...
Devdiscourse10d
Health Headlines: Major Drug Halts, Egg Price Probe, and More
The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...